A prescribing practitioner who makes a finding under Subsection (5)(a) for a patient with a
seizure disorder shall indicate a prohibition on substitution of a drug product equivalent in the manner
provided in Subsections (5)(a) or (b).
(c)
Except as provided in Subsection (7)
{
(c)
}
(d)
, a pharmacist or pharmacy intern
who
cannot dispense the prescribed drug as written, and who needs to substitute
86
{
substitutes
}
a drug product equivalent for
{
an epilepsy
}
the
drug prescribed to
{
a
}
the
patient to treat or
87
prevent seizures shall notify the prescribing practitioner prior to the substitution.
88
{
(c)
}
(d)
Notification under Subsection (7)
{
(b)
}
(c)
is not required if the drug
product equivalent is
89
paid for in whole or in part by Medicaid.
Page 1 of 1
LRGC
cdupont
cdupont